首页> 美国卫生研究院文献>Clinical and Experimental Immunology >Suppression of lymphokine-activated killer (LAK) cell induction mediated by interleukin-4 and transforming growth factor-beta 1: effect of addition of exogenous tumour necrosis factor-alpha and interferon-gamma and measurement of their endogenous production.
【2h】

Suppression of lymphokine-activated killer (LAK) cell induction mediated by interleukin-4 and transforming growth factor-beta 1: effect of addition of exogenous tumour necrosis factor-alpha and interferon-gamma and measurement of their endogenous production.

机译:抑制白介素4和转化生长因子β介导的淋巴因子激活的杀伤细胞(LAK)的诱导1:添加外源性肿瘤坏死因子α和干扰素γ的作用及其内源性产生的测量。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Recombinant human interleukin-4 (rhIL-4) and transforming growth factor-beta 1 (TGF-beta 1) suppressed the induction of lymphokine-activated killer (LAK) activity induced by recombinant human interleukin-2 (rhIL-2) in peripheral blood lymphocytes. DNA synthesis and the expression of the p55 alpha chain of the IL-2 receptor (Tac antigen) were also inhibited. The inhibitory effect was greatest when these factors were added during the first 48 h of a 4-day culture, with reduced cytolytic activity against both natural killer (NK) resistant and NK-sensitive tumour cell line targets. The suppressive action of both cytokines was accompanied by a reduction in tumour necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma) levels in lymphocyte culture supernatants. Recombinant human IFN-gamma (rhIFN-gamma), but not recombinant human TNF-alpha (rhTNF-alpha) was able to overcome the inhibitory effect of recombinant human interleukin-4 (rhIL-4) on LAK induction and DNA synthesis but not Tac antigen expression. However, cytotoxicity induced by rhIFN-gamma alone was also suppressed by rhIL-4 and TGF-beta 1, inferring that rhIFN-gamma-mediated abrogation of rhIL4 suppression was not simply a direct IL-2-independent effect on cytotoxicity. In addition, rhIL-4 did not increase TGF-beta production from rhIL-2-activated peripheral blood mononuclear cells, suggesting that rhIL-4 did not mediate reduction of rhIL-2 responses through the induction of TGF-beta release.
机译:重组人白介素4(rhIL-4)和转化生长因子β1(TGF-beta 1)抑制了外周血中重组人白介素2(rhIL-2)诱导的淋巴因子激活的杀手(LAK)活性的诱导。淋巴细胞。还抑制了DNA合成以及IL-2受体(Tac抗原)的p55α链的表达。当在4天培养的最初48小时内添加这些因子时,抑制作用最大,对自然杀伤(NK)抗性和NK敏感肿瘤细胞系靶标的细胞溶解活性降低。两种细胞因子的抑制作用都伴随着淋巴细胞培养上清液中肿瘤坏死因子-α(TNF-α)和干扰素-γ(IFN-γ)水平的降低。重组人IFN-γ(rhIFN-γ)而非重组人TNF-α(rhTNF-alpha)能够克服重组人白介素4(rhIL-4)对LAK诱导和DNA合成的抑制作用,但不能克服Tac抗原表达。但是,仅由rhIFN-γ诱导的细胞毒性也被rhIL-4和TGF-β1抑制,这表明rhIFN-γ介导的对rhIL4抑制的废除不仅仅是对细胞毒性的直接IL-2独立作用。此外,rhIL-4不会增加由rhIL-2活化的外周血单核细胞产生的TGF-β,这表明rhIL-4不会通过诱导TGF-β释放来介导rhIL-2应答的降低。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号